Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
reported post-VSG increases in lumbar BMAT alongside peripheral MAT reductions, underscoring region-specific fatbone interactions, although other studies report a reduction in BMAT with VSG
PMID 15128440
Lv Q, Wang L, Luo X, Chen X
Results were reduced in those with T2D, but still significant (STEP-2) [94]
The FDA-approved prescribing information recommends rotating injection sites with each dose to reduce the risk of lipodystrophy and injection site reactions
US$ 21.80
US$ 28.35
US$ 21.41
US$ 24.38
US$ 21.87
